Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $20.2M | $749.0K | $14.0M | $1,000.0K | $15.2M | $24.4M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Aadi Bioscience, Inc.'s last 12-month Revenue is $25.1M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Aadi Bioscience, Inc.'s Revenue growth was 7.8%. The average annual Revenue growth rates for Aadi Bioscience, Inc. have been 20.2% over the past three years, 551.0% over the past five years.
Over the last year, Aadi Bioscience, Inc.'s Revenue growth was 7.8%, which is higher than industry growth of 3.0%. It indicates that Aadi Bioscience, Inc.'s Revenue growth is Good.